Upcoming Presentations
February 11-13, 2004
Scientific & Technological Advances In
Cancer Research
Hyatt Regency Reston
Reston, VA
Integrated
Approaches to Effective Detection, Prognosis and Treatment of Cancer
SurroMed - Conference Exhibitor
http://www.LifeSciencesInfo.com/cancer/?source=3025-40
December 08-10, 2003
CHI-Metabolic Profiling: Pathways in
Discovery
Princeton, NJ
Global Differential Expression Profiling for
Metabolic Biomarker Discovery: Advances and Challenges
Haihong Zhou, PhD
October 29-30, 2003
IBC - Systems Biology for Drug
Discovery and Development
Boston, MA
Comprehensive Phenotyping Enables a Systems
Biology Approach to Studying Disease
Aaron B. Kantor, PhD
October 08-10, 2003
2003 Insightful Technology Conference
Las Vegas, NV
SurroStat™, an Analysis Workflow Tool for
Biomarker Discovery
Meir Pinco, PhD
September 15-16, 2003
IBC Meeting - Systems Biology
Jurys Hotel Great Russell Street
London, England
Capturing, Integrating and Analyzing Large Amounts
of Clinical and Biological Information to Identify Biomarkers and
Pathways Involved in Disease and Therapeutic Response.
Howard Schulman, Ph.D., Vice President
of Research and Development
July 28-29, 2003
IIR - The What, Where and When of
Biomarkers from Discovery to Utility
Philadelphia, PA
Biomarker Discovery by Comprehensive Phenotyping
through Integrating Bioanalytical Platforms and Clinical Research
Aaron B. Kantor, PhD
July 14-15, 2003
SRI - Biomarkers and
Pharmaco-Proteomis. Speeding Discovery and Development.
Philadelphia, PA
TBD
Howard Schulman, Ph.D., Vice President
of Research and Development
June 30-July 2, 2003
IBC - Proteomics and the Proteome
Conference
Basel, Switzerland
TBD
Howard Schulman, Ph.D., Vice President
of Research and Development
June 8-12, 2003
ASMS, Annual ASMS Conference on Mass
Spectrometry and Allied Topics 51st Annual Conference
Montreal, Canada
Quantitative Proteomics in 2D-LC/MS: Automated
Quantitative Profiling and Identification of Low-abundance Proteins in
Human Serumx
Sushmita Mimi Roy, Ph.D.
June 8-12 2003
ASMS, Annual ASMS Conference on Mass
Spectrometry and Allied Topics 51st Annual Conference
Montreal, Canada
Cerebrospinal Fluid Metabolomics: A Systems
Approach for Biomarker Discovery (Zhou H., Frenzel G., Becker C. (2003))
Haihong Zhou
May 28-30, 2003
IBC Conference - Molecular
Diagnostics/Personalized Medicine
Seaport Hotel
Boston, MA
Biomarker-enabled Drug Discovery and Development
Howard Schulman, Ph.D., Vice President
of Research and Development
May 15-19, 2003
FOCIS 2003 - Meeting of the Federation
of Clinical Immunology Societies
La Maison de la Chimie
Paris, France
Biomarker Discovery by Comprehensive Phenotyping
for Autoimmune Diseases
Aaron B. Kantor, PhD
May 6-9, 2003
International Society for Analytical
Cytometry (ISAC)
1st International Cytomics Conference
The Celtic Manor Resort
Coldra Woods, Newport Wales
Biomarker Discovery by Comprehensive Phenotyping
Aaron B. Kantor
April 6-9, 2003
IBC, Delivering New Routes to Drug
Discovery
San Diego, CA
Quantitative Proteomics: Biomarker Discovery
through Protein and Metabolite Profiling
Sushmita Mimi Roy, Ph.D.
March 26,
2003
Keystone Symposia
Proteomics: Technologies and Applications
Keystone, Colorado
Longitudinal Study of Rheumatoid Arthritis by Mass
Spectrometry: Serum Proteins and Metabolites
Christopher Becker, Ph.D., Director Chemistry
February 10, 2003
IBC and NCI, Genomic and Proteomic
Technological Advances in Cancer Research
Bethesda, Maryland
Quantitative Proteomics: Biomarker Discovery
through Protein and Metabolite Profiling
Sushmita Mimi Roy, Ph.D.